Management of high blood pressure in diabetes mellitus: lessons from The ADA Recommendation.
Waspadji
Sarwono
S
Division of Endocrinology and Metabolism, Deparment of Internal Medicine, Faculty of Medicine, University of Indonesia-Dr. Cipto Mangunkusumo Hospital, Jakarta.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000145:classification / Q000627:therapeutic use; D048909:Diabetes Complications; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology; D007214:Indonesia; D017410:Practice Guidelines as Topic; D014481:United States; D014837:Voluntary Health Agencies
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents